Prediction of conversion to psychosis in individuals with an at-risk mental state: A brief update on recent developments

Current Opinion in Psychiatry

Volumn 30, Issue 3, 2017, Pages 209-219

  Riecher Rössler, Anita ^a   Studerus, Erich ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Conversion; Prediction; Psychosis; Schizophrenia; Transition

Indexed keywords

BIOLOGICAL MARKER; STRESS HORMONE;

ACCURACY; ANHEDONIA; CANNABIS ADDICTION; CONVERSION DISORDER; DISEASE SEVERITY; DISORDERS OF HIGHER CEREBRAL FUNCTION; ELECTROENCEPHALOGRAPHY; HIGH RISK POPULATION; HUMAN; MENTAL DISEASE; NERVOUS SYSTEM INFLAMMATION; NEUROIMAGING; NEUROPHYSIOLOGY; PREDICTIVE VALUE; PSYCHOSIS; REVIEW; RISK ASSESSMENT; SOCIAL INTERACTION; STRESS; SUSPICIOUSNESS; DISEASE COURSE; PSYCHOTIC DISORDERS; STANDARDS;

DISEASE PROGRESSION; HUMANS; PSYCHOTIC DISORDERS; RISK ASSESSMENT;

EID: 85013046214     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000320     Document Type: Review

References (85)

1. Häfner H, Riecher-Rössler A, An Der Heiden W, et al. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 1993;23:925-940.
2. Yung AR, Phillips LJ, McGorry PD, et al. Prediction of psychosis. A step towards indicated prevention of schizophrenia. Br J Psychiatry Suppl 1998;172:14-20.
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
4. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry 2013;70:107-120.
5. Schultze-Lutter F, Michel C, Schmidt SJ, et al. EPA guidance on the early detection of clinical high risk states of psychoses. Eur Psychiatry 2015;30:405-416.
6. Fusar-Poli P, Rocchetti M, Sardella A, et al. Disorder, not just state of risk: meta-analysis of functioning and quality of life in people at high risk of psychosis. Br J Psychiatry 2015;207:198-206.
7. van Donkersgoed RJ, Wunderink L, Nieboer R, et al. Social cognition in individuals at ultra-high risk for psychosis. A meta-analysis. PLoS One 2015;10:e0141075.
8. Kraan T, Velthorst E, Koenders L, et al. Cannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis. Psychol Med 2016;46:673-681.
9. Chaumette B, Kebir O, Mam-Lam-Fook C, et al. Salivary cortisol in early psychosis: new findings and meta-analysis. Psychoneuroendocrinology 2016;63:262-270.
10. Schmidt A, Cappucciati M, Radua J, et al. Improving prognostic accuracy in subjects at clinical high risk for psychosis: systematic review of predictive models and meta-analytical sequential testing simulation. Schizophr Bull 2016. doi: 10.1093/schbul/sbw098.
11. Fusar-Poli P, Cappucciati M, Borgwardt S, et al. Heterogeneity of psychosis risk within individuals at clinical high risk: a meta-analytical stratification. JAMA Psychiatry 2016;73:113-120.
12. Fusar-Poli P, Schultze-Lutter F, Cappucciati M, et al. The dark side of the moon: meta-analytical impact of recruitment strategies on risk enrichment in the clinical high risk state for psychosis. Schizophr Bull 2016;42:732-743.
13. Fusar-Poli P, Cappucciati M, Rutigliano G, et al. At risk or not at risk? A metaanalysis of the prognostic accuracy of psychometric interviews for psychosis prediction. World Psychiatry 2015;14:322-332.
14. Kempton MJ, Bonoldi I, Valmaggia L, et al. Speed of psychosis progression in people at ultra-high clinical risk: a complementary meta-analysis. JAMA Psychiatry 2015;72:622-623.
15. Nelson B, Yuen HP, Wood SJ, et al. Long-term follow-up of a group at ultra high risk ('prodromal') for psychosis: the PACE 400 study. JAMA Psychiatry 2013;70:793-802.
16. Cornblatt BA, Carrion RE, Auther A, et al. Psychosis prevention: a modified clinical high risk perspective from the Recognition and Prevention (Rap) Program. Am J Psychiatry 2015;172:986-994.
17. Beck K, Andreou C, Studerus E, et al. Long-term rates of remission and late psychotic transition of individuals at risk for psychosis. 25th European Congress of Psychiatry 1-4 April 2017, Florence accepted abstract.
18. Carrion RE, Demmin D, Auther AM, et al. Duration of attenuated positive and negative symptoms in individuals at clinical high risk: associations with risk of conversion to psychosis and functional outcome. J Psychiatr Res 2016;81:95-101.
19. Zhang TH, Li HJ, Woodberry KA, et al. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, helpseeking and conversion. Epidemiol Psychiatr Sci 2016. doi: 10.1017/ s2045796016000184:1-12.
20. Perkins DO, Jeffries CD, Cornblatt BA, et al. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophr Res 2015;169:169-177.
21. Flückiger R, Ruhrmann S, Debbane M, et al. Psychosis-predictive value of selfreported schizotypy in a clinical high-risk sample. J Abnorm Psychol 2016;125:923-932.
22. O'Connor K, Nelson B, Lin A, et al. Are UHR patients who present with hallucinations alone at lower risk of transition to psychosis? Psychiatry Res 2016;235:177-196.
23. Azar M, Pruessner M, Baer LH, et al. A study on negative and depressive symptom prevalence in individuals at ultra-high risk for psychosis. Early Interv Psychiatry 2016. doi: 10.1111/eip.12386.
24. McAusland L, Buchy L, Cadenhead KS, et al. Anxiety in youth at clinical high risk for psychosis. Early Interv Psychiatry 2015. doi: 10.1111/eip.12274.
25. Armando M, Pontillo M, De Crescenzo F, et al. Twelve-month psychosispredictive value of the ultra-high risk criteria in children and adolescents. Schizophr Res 2015;169:186-192.
26. Mamah D, Musau A, Mutiso VN, et al. Characterizing psychosis risk traits in Africa: a longitudinal study of Kenyan adolescents. Schizophr Res 2016;176:340-348.
27. Mechelli A, Lin A, Wood S, et al. Using clinical information to make individualized prognostic predictions in people at ultra high risk for psychosis. Schizophr Res 2016. doi: 10.1016/j.schres.2016.11.047.
28. Addington J, Liu L, Perkins DO, et al. The role of cognition and social functioning as predictors in the transition to psychosis for youth with attenuated psychotic symptoms. Schizophr Bull 2016;10.1093/schbul/sbw152.
29. McLaughlin D, Carrion RE, Auther AM, et al. Functional capacity assessed by the map task in individuals at clinical high-risk for psychosis. Schizophr Bull 2016;42:1234-1242.
30. Murray RM, Quigley H, Quattrone D, et al. Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis. World Psychiatry 2016;15:195-204.
31. McHugh MJ, McGorry PD, Yung AR, et al. Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis. Psychol Med 2016. doi: 10.1017/S0033291716002671:1-11.
32. Xu L, Zhang T, Zheng L, et al. Psychometric properties of prodromal questionnaire- brief version among Chinese help-seeking individuals. PLoS One 2016;11:e0148935.
33. Maurer K, Zink M, Rausch F, et al. The early recognition inventory ERIraos assesses the entire spectrum of symptoms through the course of an at-risk mental state. Early Interv Psychiatry 2016. doi: 10.1111/eip.12305.
34. Kammermann J, Stieglitz RD, Riecher-Rössler A. Self-screen prodrome: selfrating for the early detection of mental disorders and psychoses. Fortschr Neurol Psychiatr 2009;77:278-284.
35. Chung Y, Jacobson A, He G, et al. Prodromal symptom severity predicts accelerated gray matter reduction and third ventricle expansion among clinically high risk youth developing psychotic disorders. Mol Neuropsychiatry 2015;1:13-22.
36. Rüsch N, Heekeren K, Theodoridou A, et al. Stigma as a stressor and transition to schizophrenia after one year among young people at risk of psychosis. Schizophr Res 2015;166:43-48.
37. Carrion RE, McLaughlin D, Auther AM, et al. The impact of psychosis on the course of cognition: a prospective, nested case-control study in individuals at clinical high-risk for psychosis. Psychol Med 2015;45:3341-3354.
38. Ramyead A, Studerus E, Kometer M, et al. Prediction of psychosis using neural oscillations and machine learning in neuroleptic-naive at-risk patients. World J Biol Psychiatry 2016;17:285-295.
39. Kraan T, van Dam DS, Velthorst E, et al. Childhood trauma and clinical outcome in patients at ultra-high risk of transition to psychosis. Schizophr Res 2015;169:193-198.
40. Mourik K, Decrescenzo P, Brucato G, et al. Various neurocognitive deficits and conversion risk in individuals at clinical high risk for psychosis. Early Interv Psychiatry 2015. doi: 10.1111/eip.12296.
41. Berger GE, Smesny S, Schafer MR, et al. Niacin skin sensitivity is increased in adolescents at ultra-high risk for psychosis. PLoS One 2016;11:e0148429.
42. Ising HK, Ruhrmann S, Burger NA, et al. Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disorders. Psychol Med 2016;46:1839-1851.
43. Kebir O, Chaumette B, Rivollier F, et al. Methylomic changes during conversion to psychosis. Mol Psychiatry 2016. doi: 10.1038/mp.2016.53.
44. Pawelczyk T, Trafalska E, Kotlicka-Antczak M, et al. The association between polyunsaturated fatty acid consumption and the transition to psychosis in ultra-high risk individuals. Prostaglandins Leukot Essent Fatty Acids 2016;108:30-37.
45. Clark SR, Baune BT, Schubert KO, et al. Prediction of transition from ultrahigh risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers. Transl Psychiatry 2016;6:e897.
46. Metzler S, Dvorsky D, Wyss C, et al. Neurocognition in help-seeking individuals at risk for psychosis: prediction of outcome after 24 months. Psychiatry Res 2016;246:188-194.
47. Kotlicka-Antczak M, Pawelczyk A, Karbownik MS, et al. Deficits in the identification of pleasant odors predict the transition of an at-risk mental state to psychosis. Schizophr Res 2016. doi: 10.1016/j.schres.2016. 10.019.
48. Seidman LJ, Shapiro DI, Stone WS, et al. Association of neurocognition with transition to psychosis: baseline functioning in the second phase of the North American Prodrome Longitudinal Study. JAMA Psychiatry 2016;73:1239-1248.
49. Lehembre-Shiah E, Leong W, Brucato G, et al. Distinct relationships between visual and auditory perceptual abnormalities and conversion to psychosis in a clinical high-risk population. JAMA Psychiatry 2016. doi: 10.1001/jamapsychiatry. 2016.3055.
50. Papmeyer M, Würsch I, Studerus E, et al. The role of vulnerability factors in individuals with an at-risk mental state of psychosis. Neuropsychiatr 2016;30:18-26.
51. Barajas A, Ochoa S, Obiols JE, et al. Gender differences in individuals at highrisk of psychosis: a comprehensive literature review. Sci World J 2015;2015:430735.
52. Cannon TD, Yu C, Addington J, et al. An individualized risk calculator for research in prodromal psychosis. Am J Psychiatry 2016;173:980-988.
53. Carrion RE, Cornblatt BA, Burton CZ, et al. Personalized prediction of psychosis: external validation of the NAPLS-2 psychosis risk calculator with the EDIPPP project. Am J Psychiatry 2016;173:989-996.
54. Hur JW, Choi SH, Yun JY, et al. Parental socioeconomic status and prognosis in individuals with ultra-high risk for psychosis: a 2-year follow-up study. Schizophr Res 2015;168:56-61.
55. Lyngberg K, Buchy L, Liu L, et al. Patterns of premorbid functioning in individuals at clinical high risk of psychosis. Schizophr Res 2015;169:209-213.
56. Stowkowy J, Liu L, Cadenhead KS, et al. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Soc Psychiatry Psychiatr Epidemiol 2016;51:497-503.
57. Schneider M, Armando M, Pontillo M, et al. Ultra high risk status and transition to psychosis in 22q11.2 deletion syndrome. World Psychiatry 2016;15:259-265.
58. Studerus E, Papmeyer M, Riecher-Rössler A, et al. Neurocognition and motor functioning in the prediction of psychosis. In: Riecher-Rössler A, McGorry P, editors. Early Detection and Intervention in Psychosis. Basel: Karger; 2016. ; 116-132.
59. Zhang T, Yi Z, Li H, et al. Faux pas recognition performance in a help-seeking population at clinical high risk of psychosis. Eur Arch Psychiatry Clin Neurosci 2016;266:71-78.
60. Bodatsch M, Brockhaus-Dumke A, Klosterkötter J, et al. Forecasting psychosis by event-related potentials-systematic review and specific meta-analysis. Biol Psychiatry 2015;77:951-958.
61. van Tricht MJ, Nieman DH, Koelman JH, et al. Auditory ERP components before and after transition to a first psychotic episode. Biol Psychol 2011;87:350-357.
62. Gifford G, Crossley N, Fusar-Poli P, et al. Using neuroimaging to help predict the onset of psychosis. Neuroimage 2016. doi: 10.1016/j.neuroimage. 2016.03.075.
63. Wang C, Ji F, Hong Z, et al. Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study. Psychol Med 2016;46:2771-2783.
64. Anticevic A, Haut K, Murray JD, et al. Association of thalamic dysconnectivity and conversion to psychosis in youth and young adults at elevated clinical risk. JAMA Psychiatry 2015;72:882-891.
65. Koutsouleris N, Riecher-Rössler A, Meisenzahl EM, et al. Detecting the psychosis prodrome across high-risk populations using neuroanatomical biomarkers. Schizophr Bull 2015;41:471-482.
66. Föcking M, Dicker P, Lopez LM, et al. Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder? BMC Psychiatry 2016;16:326.
67. Perkins DO, Jeffries CD, Addington J, et al. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophr Bull 2015;41:419-428.
68. Chan MK, Krebs MO, Cox D, et al. Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset. Transl Psychiatry 2015;5:e601.
69. Labad J, Stojanovic-Perez A, Montalvo I, et al. Stress biomarkers as predictors of transition to psychosis in at-risk mental states: roles for cortisol, prolactin and albumin. J Psychiatr Res 2015;60:163-169.
70. Riecher-Rössler A. Estrogens, prolactin, hypothalamo-pituitary-gonadal axis and schizophrenic psychoses: a systematic review. Lancet Psychiatry 2017;4:63-72.
71. Kraan TC, Ising HK, Fokkema M, et al. The effect of childhood adversity on 4- year outcome in individuals at ultra high risk for psychosis in the Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial. Psychiatry Res 2016;247:55-62.
72. Hartmann JA, Yuen HP, McGorry PD, et al. Declining transition rates to psychotic disorder in 'ultra-high risk' clients: investigation of a dilution effect. Schizophr Res 2016;170:130-136.
73. Wiltink S, Velthorst E, Nelson B, et al. Declining transition rates to psychosis: the contribution of potential changes in referral pathways to an ultra-high-risk service. Early Interv Psychiatry 2015;9:200-206.
74. Nelson B, Yuen HP, Lin A, et al. Further examination of the reducing transition rate in ultra high risk for psychosis samples: the possible role of earlier intervention. Schizophr Res 2016;174:43-49.
75. European Network of National Networks studying Gene-Environment Interactions. van Os SJ, Rutten BP, Myin-Germeys I, et al. Identifying gene- environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations. Schizophr Bull 2014;40:729-736.
76. Addington J, Cadenhead KS, Cornblatt BA, et al. North American Prodrome Longitudinal Study (NAPLS 2): overview and recruitment. Schizophr Res 2012;142:77-82.
77. Koutsouleris N, Davatzikos C, Bottlender R, et al. Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull 2012;38:1200-1215.
78. Studerus E, Ramyead A, Riecher-Rössler A. Prediction of transition to psychosis in patients with a clinical high risk for psychosis: a systematic review of methodology and reporting. Psychol Med 2017. doi: 10.1017/ S0033291716003494:1-16.
79. Moons KG, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med 2015;162:W1-73.
80. Collins GS, Reitsma JB, Altman DG, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 2015;350:g7594.
81. Riecher-Rössler A, Studerus E. High time for a paradigm shift in psychiatry. World Psychiatry 2016;15:131-133.
82. Selvendra A, Baetens D, Trauer T, et al. First episode psychosis in an adult area mental health service-a closer look at early and late-onset first episode psychosis. Australas Psychiatry 2014;22:235-241.
83. Simon GE, Coleman KJ, Yarborough BJ, et al. First presentation with psychotic symptoms in a population-based sample. Psychiatr Serv 2017. doi: 10.1176/appi.ps.201600257: appips201600257]
84. Häfner H, Maurer K, Löffler W, et al. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993;162:80-86.
85. Lin A, Wood SJ, Yung AR. Measuring psychosocial outcome is good. Curr Opin Psychiatry 2013;26:138-143.